[Image courtesy of Prof. Johannes Kaesmacher, Inselspital, Bern University Hospital, Switzerland/Siemens Healthineers]
The companies aim to accelerate the adoption of cone-beam CT perfusion (CBCT-P). They hope to leverage its capability to show the flow of blood through the brain’s tissue and visualize how well different areas are being supplied with oxygen and nutrients.
According to a news release, the collaboration combines the Cercare Medical Neurosuite (CMN) with Siemens Healthineers’ imaging technology. Cercare has an integrated portfolio of advanced, vendor-neutral imaging software solutions that deliver automated perfusion analysis. The technology works across computed tomography (CT), MRI and CBCT with Siemens Healthineers’ Syngo DynaCT Multiphase. Syngo DynaCT Multiphase, a 3D acquisition protocol, enables up to 10 CBCT angiography phases.
Siemens Healthineers says the two solutions combined enable advanced perfusion and metabolic imaging directly in the angiography suite. This helps clinicians diagnose stroke during intervention. According to Siemens Healthineers, the joint offering can reduce the need to transfer patients from the angiography room to the imaging modality.
The integrated platform could streamline workflows and shorten the time to critical stroke treatments.
Siemens Healthineers and Cercare established the scientific foundation of their solution in close collaboration with Dr. Johannes Kaesmacher at Inselspital, Bern University Hospital, Switzerland. They also have projects underway at three other leading hospitals.
Commentary from company officials
Henrik Andersen, chief commercial officer, Cercare Medical said:
“This collaboration allows us to scale perfusion imaging globally. Through our standalone Cercare Medical Neurosuite offering, we can address perfusion-only opportunities while ensuring flexibility for stroke centers seeking advanced decision support directly in the angio suite.”
Carsten Bertram, head of Advanced Therapies at Siemens Healthineers, said:
“By combining Cercare’s advanced perfusion software with our Syngo DynaCT technology, we deliver a comprehensive solution that supports clinicians to care for their patients across the full treatment pathway. Together, we are enabling a new standard in interventional stroke care.”
Kaesmacher added:
“You can only treat what you can see. CBCT perfusion delivers crucial insights right in the angio suite, when standard imaging like CT or MR is not immediately available. “This supports real-time imaging guided decision making in the acute phase of treatment. This includes the assessment of residual occlusions, no reflow, and complications as well as predicting brain tissue viability and clinical outcomes.”
